1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZNF84 CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA NPIPA8 CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA FKBP6 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA CFD CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA DEF8 CTRPv2 pan-cancer AAC -0.18 2e-07
mRNA BRD3 CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA ZNF345 CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA ZNF491 CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA ZBED4 CTRPv2 pan-cancer AAC 0.21 2e-07
mRNA RP11-795F19.5 CTRPv2 pan-cancer AAC 0.19 3e-07
Download CSV